NEU 2.23% $19.73 neuren pharmaceuticals limited

Interesting question" As far as I am aware (I am clinical not...

  1. 122 Posts.
    lightbulb Created with Sketch. 79
    Interesting question" As far as I am aware (I am clinical not research), the answer is yes. Many examples in oncology, and the whole idea of re-purposing drugs, in essence, utilises this pathway. Might well be something neuren are thinking of!
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.